Prognostic factors associated with resectable carcinoma of the esophagus

American Surgeon

Volumn 68, Issue 3, 2002, Pages 258-262

  Christein, John D ^a   Hollinger, Edward F ^a   Millikan, Keith W ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b University Surgeons   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANAMNESIS; BLOOD TRANSFUSION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIA CARCINOMA; CELL DIFFERENTIATION; CONFERENCE PAPER; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PEROPERATIVE CARE; PROGNOSIS; SURGICAL MORTALITY; TUMOR LOCALIZATION; UNIVARIATE ANALYSIS; WEIGHT REDUCTION; ANALYSIS OF VARIANCE; ARTICLE; CANCER STAGING; CARCINOMA; COMPARATIVE STUDY; CONFIDENCE INTERVAL; ESOPHAGUS TUMOR; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; POSTOPERATIVE COMPLICATION; PROBABILITY; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA; CONFIDENCE INTERVALS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036518317     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Greenlee RT, Hill-Harmon M, Murray T, et al. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
2. Daly JM, Fry WA, Little AG, et al. Esophageal cancer: Results of an American College of Surgeons patient care evaluation study. J Am Coll Surg 2000;190:562-73.
3. Millikan KW, Silverstein J, Hart V, et al. A 15-year review of esophagectomy for carcinoma of the esophagus and cardia Arch Surg 1995;130:617-24.
4. Gluch L, Smith RC, Bambach CP, et al. Comparison of the outcomes following transhiatal or Ivor Lewis esophagectomy for esophageal carcinoma. World J Surg 1999;23:271-6.
5. Walsh TN, Noonan MB, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-7.
6. Wolfe WG, Vaughn AL, Seigler HF, et al. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy. J Thorac Cardiovasc Surg 1993;105:749-56.
7. Karl RC, Schreiber R, Boulware D, et al. Factors affecting morbidity, mortality and survival in patients undergoing Ivor Lewis esophagogastrectomy. Ann Surg 2000;231:635-43.
8. Rice TW, Zuccaro G Jr, Adelstein DJ, et al. Depth of tumor invasion (T) is predictive of regional lymph node status (N) for esophageal carcinoma. Ann Thorac Surg 1998;65:787-92.
9. Swisher SG, Holmes EC, Hunt KK, et al. Perioperative blood transfusions and decreased long-term survival in esophageal cancer. J Thorac Cardiovasc Surg 1996;112:341-8.
10. Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy: Clinical experience and refinements. Ann Surg 1999;230:392-403.
11. King RM, Pairolero PC, Trastek VF, et al. Ivor Lewis esophagogastrectomy for carcinoma of the esophagus: Early and late functional results. Ann Thorac Surg 1987;44:119-22.
12. Hagen JA, Peters JH, DeMeester TR. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg 1993;106:850-9.
13. Edna TH, Bjerkset T. Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer. Dis Colon Rectum 1998;41:451-9.
14. Fong Y, Karpeh M, Mayer K, et al. Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg 1994;167:256-60.
15. Millikan KW, Deziel DJ, Silverstein JC, et al. Prognostic factors associated with resectable adenocarcinoma of the head pancreas. Am Surg 1999;65:618-24.